The current work aims to provide the reader with an updated review of inflammation biomarkers research in ADPKD, highlighting the role of urinary MCP-1 (monocyte chemoattractant protein-1) as the most promising tool. The gene discussed is CCL2; the disease is autosomal dominant polycystic kidney disease.